Both in Pharmaceuticals
Nurix Therapeutics vs Nuvation Bio
Over the past year NRIX returned +30.1% and NUVB returned −2.1%; their daily moves had a correlation of 0.26.
NRIX +30.1% NUVB −2.1%Growth of $1, one year, split-adjusted
| Metric | NRIX | NUVB |
|---|---|---|
| Price | $15.95 | $4.73 |
| Market cap | $1.74B | $1.66B |
| Today | −38.23% | +0.85% |
| 1 month | −29.4% | −3.1% |
| 6 months | −5.5% | −6.2% |
| Year to date | −15.9% | −47.2% |
| 1 year | +26.4% | −8.5% |
| Revenue growth (YoY) | +8426.3% | +555.6% |
| Gross margin | 100.0% | 73.0% |
| Net margin | 81.7% | −198.3% |
| P/E (TTM) | 5.9× | — |
| Price / sales | 2.5× | 9.8× |
| Net cash | $1.05B | $399.4M |
| Dividend yield | — | — |
| Volatility (60d) | 104.6% | 50.8% |
| Short % of float | 21.0% | 23.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).